annual D&A:
$18.00K-$11.00K(-37.93%)Summary
- As of today (July 1, 2025), AKRO annual depreciation & amortization is $18.00 thousand, with the most recent change of -$11.00 thousand (-37.93%) on December 31, 2024.
- During the last 3 years, AKRO annual D&A has fallen by -$23.00 thousand (-56.10%).
- AKRO annual D&A is now -58.14% below its all-time high of $43.00 thousand, reached on December 31, 2022.
Performance
AKRO Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$0.00-$15.00K(-100.00%)Summary
- As of today (July 1, 2025), AKRO quarterly depreciation & amortization is $0.00, with the most recent change of -$15.00 thousand (-100.00%) on March 31, 2025.
- Over the past year, AKRO quarterly D&A has dropped by -$1000.00 (-100.00%).
- AKRO quarterly D&A is now -100.00% below its all-time high of $15.00 thousand, reached on December 31, 2024.
Performance
AKRO quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$17.00K-$1000.00(-5.56%)Summary
- As of today (July 1, 2025), AKRO TTM depreciation & amortization is $17.00 thousand, with the most recent change of -$1000.00 (-5.56%) on March 31, 2025.
- Over the past year, AKRO TTM D&A has dropped by -$2000.00 (-10.53%).
- AKRO TTM D&A is now -61.36% below its all-time high of $44.00 thousand, reached on September 30, 2022.
Performance
AKRO TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
AKRO Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -37.9% | -100.0% | -10.5% |
| 3 y3 years | -56.1% | -100.0% | -58.5% |
| 5 y5 years | +100.0% | 0.0% | +100.0% |
AKRO Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -58.1% | at low | -100.0% | at low | -61.4% | +240.0% |
| 5 y | 5-year | -58.1% | >+9999.0% | -100.0% | at low | -61.4% | >+9999.0% |
| alltime | all time | -58.1% | >+9999.0% | -100.0% | at low | -61.4% | >+9999.0% |
AKRO Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $0.00(-100.0%) | $17.00K(-5.6%) |
| Dec 2024 | $18.00K(-37.9%) | $15.00K(+1400.0%) | $18.00K(+260.0%) |
| Sep 2024 | - | $1000.00(0.0%) | $5000.00(-44.4%) |
| Jun 2024 | - | $1000.00(0.0%) | $9000.00(-52.6%) |
| Mar 2024 | - | $1000.00(-50.0%) | $19.00K(-34.5%) |
| Dec 2023 | $29.00K(-32.6%) | $2000.00(-60.0%) | $29.00K(-21.6%) |
| Sep 2023 | - | $5000.00(-54.5%) | $37.00K(-14.0%) |
| Jun 2023 | - | $11.00K(0.0%) | $43.00K(0.0%) |
| Mar 2023 | - | $11.00K(+10.0%) | $43.00K(0.0%) |
| Dec 2022 | $43.00K | $10.00K(-9.1%) | $43.00K(-2.3%) |
| Sep 2022 | - | $11.00K(0.0%) | $44.00K(+4.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $11.00K(0.0%) | $42.00K(+2.4%) |
| Mar 2022 | - | $11.00K(0.0%) | $41.00K(0.0%) |
| Dec 2021 | $41.00K(+141.2%) | $11.00K(+22.2%) | $41.00K(0.0%) |
| Sep 2021 | - | $9000.00(-10.0%) | $41.00K(+7.9%) |
| Jun 2021 | - | $10.00K(-9.1%) | $38.00K(+35.7%) |
| Mar 2021 | - | $11.00K(0.0%) | $28.00K(+64.7%) |
| Dec 2020 | $17.00K(>+9900.0%) | $11.00K(+83.3%) | $17.00K(+183.3%) |
| Sep 2020 | - | $6000.00(>+9900.0%) | $6000.00(>+9900.0%) |
| Jun 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2019 | $0.00 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2019 | - | $0.00 | $0.00 |
FAQ
- What is Akero Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Akero Therapeutics?
- What is Akero Therapeutics annual D&A year-on-year change?
- What is Akero Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Akero Therapeutics?
- What is Akero Therapeutics quarterly D&A year-on-year change?
- What is Akero Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Akero Therapeutics?
- What is Akero Therapeutics TTM D&A year-on-year change?
What is Akero Therapeutics annual depreciation & amortization?
The current annual D&A of AKRO is $18.00K
What is the all time high annual D&A for Akero Therapeutics?
Akero Therapeutics all-time high annual depreciation & amortization is $43.00K
What is Akero Therapeutics annual D&A year-on-year change?
Over the past year, AKRO annual depreciation & amortization has changed by -$11.00K (-37.93%)
What is Akero Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of AKRO is $0.00
What is the all time high quarterly D&A for Akero Therapeutics?
Akero Therapeutics all-time high quarterly depreciation & amortization is $15.00K
What is Akero Therapeutics quarterly D&A year-on-year change?
Over the past year, AKRO quarterly depreciation & amortization has changed by -$1000.00 (-100.00%)
What is Akero Therapeutics TTM depreciation & amortization?
The current TTM D&A of AKRO is $17.00K
What is the all time high TTM D&A for Akero Therapeutics?
Akero Therapeutics all-time high TTM depreciation & amortization is $44.00K
What is Akero Therapeutics TTM D&A year-on-year change?
Over the past year, AKRO TTM depreciation & amortization has changed by -$2000.00 (-10.53%)